financetom
Business
financetom
/
Business
/
Bill Ackman's Pershing Square sells 10% stake to raise $1.05 billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bill Ackman's Pershing Square sells 10% stake to raise $1.05 billion
Jun 3, 2024 4:52 AM

(Reuters) -Billionaire Bill Ackman's Pershing Square Capital Management has raised $1.05 billion by selling 10% stake in the hedge fund to a consortium of institutional investors and family offices, it said on Monday.

The sale is a precursor to a potential initial public offering that could happen next year or in 2026. Investors are valuing the firm at $10.5 billion, Reuters reported last week.

Investment firm ICONIQ, specialty insurer Arch Capital Group, investment bank BTG Pactual, Israeli insurer Menora Mivtachim, investment manager Consulta and an international group of family offices took part in the fundng.

"This new investment will help accelerate our growth in assets under management in existing and new strategies," CEO Ackman said.

About $500 million of the money raised will anchor Ackman's new investment portfolio in the United States, which will be listed on the New York Stock Exchange.

BofA Securities, Citigroup, Evolve, Jefferies, and UBS Investment Bank were the placement agents for the funding round.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Predictive Oncology Shares Tuesday?
What's Going On With Predictive Oncology Shares Tuesday?
Mar 25, 2025
Predictive Oncology, Inc. ( POAI ) shares are trading higher on Tuesday after the company announced it developed predictive models to target various cancer types. The Details: The models were developed using 21 unique compounds from the University of Michigan's Natural Products Discovery Core, which were tested for their effectiveness against cancers such as breast, colon and ovarian. The collaboration...
Signal head defends messaging app's security after US war plan leak
Signal head defends messaging app's security after US war plan leak
Mar 25, 2025
LONDON, March 25 (Reuters) - The president of Signal defended the messaging app's security on Wednesday after top Trump administration officials mistakenly included a journalist in an encrypted chatroom they used to discuss a looming U.S. attack on Yemen's Houthis. Signal's Meredith Whittaker did not directly address the blunder, which Democratic lawmakers have said was a breach of U.S. national...
Organovo Completes Sale of FXR Program to Eli Lilly
Organovo Completes Sale of FXR Program to Eli Lilly
Mar 25, 2025
11:52 AM EDT, 03/25/2025 (MT Newswires) -- Organovo ( ONVO ) said Tuesday that it has completed the sale of its farnesoid X receptor, or FXR, program to Eli Lilly ( LLY ) . The agreement was announced in February, with Organovo ( ONVO ) saying it will sell the FXR program for an upfront payment of $10 million and...
What's Going On With Alumis Shares Tuesday?
What's Going On With Alumis Shares Tuesday?
Mar 25, 2025
Alumis, Inc. ( ALMS ) stock is trading higher on Tuesday after the company announced it entered into a collaboration and licensing agreement with Kaken Pharmaceuticals. What To Know: Under the agreement, Alumis ( ALMS ) is licensing ESK-001, a drug aimed at treating immune dysregulation in various diseases, to Kaken for development, manufacturing and commercialization in Japan, limited to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved